BeiGene Presents Updated Head to Head Results from Phase 3

 PDF   10   06/2020

BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström’s Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program

¿Necesita más información?
Service